Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

30.91
Delayed Data
As of 4:03pm ET
 -0.24 / -0.77%
Today’s Change
26.97
Today|||52-Week Range
34.88
-8.95%
Year-to-Date
Analysts' Actions -- GE, Nordstrom, Rockwell Collins, Sprint and More
8:08am / TheStreet.com - Paid Partner Content
Relypsa Finally Finds Buyer, But Potential Seen For Rival Bid
Jul 21 / TheStreet.com - Paid Partner Content
In Case You Missed It, 5 New Lung Cancer Drugs Have Been Approved Since October
Jul 23 / MotleyFool.com - Paid Partner Content
Heavy Volume And Pre-Market Movement For AstraZeneca (AZN)
Jul 21 / TheStreet.com - Paid Partner Content
European Stock Markets Mixed After Signs of Brexit Damage
Jul 22 / TheStreet.com - Paid Partner Content
AstraZeneca (AZN) Is Today's Storm The Castle Stock
Jul 20 / TheStreet.com - Paid Partner Content
Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly
Jul 21 / MotleyFool.com - Paid Partner Content
Valeant/Progenics Relistor Ok'd; FDA Panel Backs Brodalumab
Jul 20 / Zacks.com - Paid Partner Content
Why Shares of Relypsa Are Soaring Today
Jul 21 / MotleyFool.com - Paid Partner Content
AstraZeneca's (AZN) Tagrisso Hits Phase III Primary Endpoint
Jul 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close31.15
Today’s open31.12
Day’s range30.75 - 31.20
Volume8,335,275
Average volume (3 months)4,747,346
Market cap$78.8B
Dividend yield4.53%
Data as of 4:03pm ET, 07/26/2016

Growth & Valuation

Earnings growth (last year)+128.05%
Earnings growth (this year)-6.22%
Earnings growth (next 5 years)+1.40%
Revenue growth (last year)-5.11%
P/E ratio26.9
Price/Sales3.48
Price/Book4.26

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-1.75-1.62%
LLYEli Lilly and Co+0.11+0.13%
ABTAbbott Laboratories+0.19+0.44%
AGNAllergan+1.10+0.44%
Data as of 4:00pm ET, 07/26/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.43
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts

Partner Offers

Search for Jobs